-
trials. Innovation and Techniques : Currently, the lab consists of a diverse group of scientists and clinicians, including stem cell biologists, immunologists, cell therapists, microbiologists, and
-
Investigator in the future. For more information on Dr. McGee’s research please visit here . As a successful candidate, you will: Devise, plan, and contribute original ideas to basic science and translational
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
mouse surgeries, including tumor implantation, tumor resection, osmotic pump implantation, and post-op monitoring. Collaborate with team members to design and execute experiments, analyze data, and
-
, and CAR-T and CAR-NK. As a successful candidate, you will: · Lead projects by designing and performing experimental procedures · Manage data, analyze, and report findings · Write
-
antibodies and CART cells, in acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL). As a successful candidate you will: · Lead projects by designing and
-
for transitional science in a vibrant, collaborative research community. Utilize FDA-approved facilities for producing investigational drugs and biologics for clinical trials. Work in facilities designed to meet
-
of novel cancer therapeutics. For more information about Dr. Perry’s lab, please visit here. As a successful candidate, you will: Devise, plan, document, and advance basic science-based projects in
-
information about Dr. Jianhua Yu’s lab, please visit here. As a successful candidate, you will: Devise, plan, document and advance basic science and translational projects in either of the following four areas
-
/surgeons to plan, design, and execute computational analyses. Advance the integration of multi-omics and clinical datasets to uncover mechanisms of tumor evolution, therapeutic resistance, and potential